Cargando…

A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma

PURPOSE: To construct a sequence diagram based on radiological and clinical factors for the evaluation of extrathyroidal extension (ETE) in patients with papillary thyroid carcinoma (PTC). MATERIALS AND METHODS: Between January 2016 and January 2020, 161 patients with PTC who underwent preoperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xian, Agyekum, Enock Adjei, Ren, Yongzhen, Zhang, Jin, Zhang, Qing, Sun, Hui, Zhang, Guoliang, Xu, Feiju, Bo, Xiangshu, Lv, Wenzhi, Hu, Shudong, Qian, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970696/
https://www.ncbi.nlm.nih.gov/pubmed/33747941
http://dx.doi.org/10.3389/fonc.2021.625646
_version_ 1783666463799771136
author Wang, Xian
Agyekum, Enock Adjei
Ren, Yongzhen
Zhang, Jin
Zhang, Qing
Sun, Hui
Zhang, Guoliang
Xu, Feiju
Bo, Xiangshu
Lv, Wenzhi
Hu, Shudong
Qian, Xiaoqin
author_facet Wang, Xian
Agyekum, Enock Adjei
Ren, Yongzhen
Zhang, Jin
Zhang, Qing
Sun, Hui
Zhang, Guoliang
Xu, Feiju
Bo, Xiangshu
Lv, Wenzhi
Hu, Shudong
Qian, Xiaoqin
author_sort Wang, Xian
collection PubMed
description PURPOSE: To construct a sequence diagram based on radiological and clinical factors for the evaluation of extrathyroidal extension (ETE) in patients with papillary thyroid carcinoma (PTC). MATERIALS AND METHODS: Between January 2016 and January 2020, 161 patients with PTC who underwent preoperative ultrasound examination in the Affiliated People’s Hospital of Jiangsu University were enrolled in this retrospective study. According to the pathology results, the enrolled patients were divided into a non-ETE group and an ETE group. All patients were randomly divided into a training cohort (n = 97) and a validation cohort (n = 64). A total of 479 image features of lesion areas in ultrasonic images were extracted. The radiomic signature was developed using least absolute shrinkage and selection operator algorithms after feature selection using the minimum redundancy maximum relevance method. The radiomic nomogram model was established by multivariable logistic regression analysis based on the radiomic signature and clinical risk factors. The discrimination, calibration, and clinical usefulness of the nomogram model were evaluated in the training and validation cohorts. RESULTS: The radiomic signature consisted of six radiomic features determined in ultrasound images. The radiomic nomogram included the parameters tumor location, radiological ETE diagnosis, and the radiomic signature. Area under the curve (AUC) values confirmed good discrimination of this nomogram in the training cohort [AUC, 0.837; 95% confidence interval (CI), 0.756–0.919] and the validation cohort (AUC, 0.824; 95% CI, 0.723–0.925). The decision curve analysis showed that the radiomic nomogram has good clinical application value. CONCLUSION: The newly developed radiomic nomogram model is a noninvasive and reliable tool with high accuracy to predict ETE in patients with PTC.
format Online
Article
Text
id pubmed-7970696
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79706962021-03-19 A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma Wang, Xian Agyekum, Enock Adjei Ren, Yongzhen Zhang, Jin Zhang, Qing Sun, Hui Zhang, Guoliang Xu, Feiju Bo, Xiangshu Lv, Wenzhi Hu, Shudong Qian, Xiaoqin Front Oncol Oncology PURPOSE: To construct a sequence diagram based on radiological and clinical factors for the evaluation of extrathyroidal extension (ETE) in patients with papillary thyroid carcinoma (PTC). MATERIALS AND METHODS: Between January 2016 and January 2020, 161 patients with PTC who underwent preoperative ultrasound examination in the Affiliated People’s Hospital of Jiangsu University were enrolled in this retrospective study. According to the pathology results, the enrolled patients were divided into a non-ETE group and an ETE group. All patients were randomly divided into a training cohort (n = 97) and a validation cohort (n = 64). A total of 479 image features of lesion areas in ultrasonic images were extracted. The radiomic signature was developed using least absolute shrinkage and selection operator algorithms after feature selection using the minimum redundancy maximum relevance method. The radiomic nomogram model was established by multivariable logistic regression analysis based on the radiomic signature and clinical risk factors. The discrimination, calibration, and clinical usefulness of the nomogram model were evaluated in the training and validation cohorts. RESULTS: The radiomic signature consisted of six radiomic features determined in ultrasound images. The radiomic nomogram included the parameters tumor location, radiological ETE diagnosis, and the radiomic signature. Area under the curve (AUC) values confirmed good discrimination of this nomogram in the training cohort [AUC, 0.837; 95% confidence interval (CI), 0.756–0.919] and the validation cohort (AUC, 0.824; 95% CI, 0.723–0.925). The decision curve analysis showed that the radiomic nomogram has good clinical application value. CONCLUSION: The newly developed radiomic nomogram model is a noninvasive and reliable tool with high accuracy to predict ETE in patients with PTC. Frontiers Media S.A. 2021-03-04 /pmc/articles/PMC7970696/ /pubmed/33747941 http://dx.doi.org/10.3389/fonc.2021.625646 Text en Copyright © 2021 Wang, Agyekum, Ren, Zhang, Zhang, Sun, Zhang, Xu, Bo, Lv, Hu and Qian http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Xian
Agyekum, Enock Adjei
Ren, Yongzhen
Zhang, Jin
Zhang, Qing
Sun, Hui
Zhang, Guoliang
Xu, Feiju
Bo, Xiangshu
Lv, Wenzhi
Hu, Shudong
Qian, Xiaoqin
A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma
title A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma
title_full A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma
title_fullStr A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma
title_full_unstemmed A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma
title_short A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma
title_sort radiomic nomogram for the ultrasound-based evaluation of extrathyroidal extension in papillary thyroid carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970696/
https://www.ncbi.nlm.nih.gov/pubmed/33747941
http://dx.doi.org/10.3389/fonc.2021.625646
work_keys_str_mv AT wangxian aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT agyekumenockadjei aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT renyongzhen aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT zhangjin aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT zhangqing aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT sunhui aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT zhangguoliang aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT xufeiju aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT boxiangshu aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT lvwenzhi aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT hushudong aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT qianxiaoqin aradiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT wangxian radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT agyekumenockadjei radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT renyongzhen radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT zhangjin radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT zhangqing radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT sunhui radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT zhangguoliang radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT xufeiju radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT boxiangshu radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT lvwenzhi radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT hushudong radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma
AT qianxiaoqin radiomicnomogramfortheultrasoundbasedevaluationofextrathyroidalextensioninpapillarythyroidcarcinoma